These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12418559

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
    Cantón R, Unal S, Farrell DJ.
    Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
    [Abstract] [Full Text] [Related]

  • 23. Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States: data from the PROTEKT US surveillance program 2000/2001.
    Waites K, Brown S.
    South Med J; 2003 Oct; 96(10):974-85. PubMed ID: 14570341
    [Abstract] [Full Text] [Related]

  • 24. [Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species].
    Marre R, Trautmann M.
    Med Klin (Munich); 1999 Nov 15; 94(11):609-13. PubMed ID: 10603732
    [Abstract] [Full Text] [Related]

  • 25. Introduction: PROTEKT against respiratory tract infection.
    Stratton CW.
    J Chemother; 2002 Jul 15; 14 Suppl 3():5-8. PubMed ID: 12418555
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Molecular analytical evaluation of macrolide- and ketolide-resistant Streptococcus pneumoniae--mechanism of action of telithromycin and resistance to it].
    Inoue M, Kaneko K, Nakano R, Sato Y, Arai S.
    Jpn J Antibiot; 2004 Oct 15; 57(5):425-37. PubMed ID: 15655904
    [Abstract] [Full Text] [Related]

  • 30. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
    Fogarty CM, Kohno S, Buchanan P, Aubier M, Baz M.
    J Antimicrob Chemother; 2003 Apr 15; 51(4):947-55. PubMed ID: 12654763
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).
    Felmingham D, Farrell DJ, Reinert RR, Morrissey I.
    J Infect; 2004 Jan 15; 48(1):39-55. PubMed ID: 14667791
    [Abstract] [Full Text] [Related]

  • 33. Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms.
    Nagai K, Hoellman D, Davies T, Jacobs M, Appelbaum P.
    Clin Microbiol Infect; 2001 Dec 15; 7(12):703-5. PubMed ID: 11843916
    [Abstract] [Full Text] [Related]

  • 34. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA, Ehrhardt AF, Jones RN.
    Am J Med; 2001 Dec 17; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
    Inoue M, Farrell DJ, Kaneko K, Akizawa K, Fujita S, Kaku M, Igari J, Yamaguchi K, Yamanaka K, Murase M, Asari S, Hirakata Y, Baba H, Itaha H.
    Microb Drug Resist; 2008 Jun 17; 14(2):109-17. PubMed ID: 18500920
    [Abstract] [Full Text] [Related]

  • 36. Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance?
    Marchese A, Schito GC.
    Int J Antimicrob Agents; 2007 Feb 17; 29 Suppl 1():S2-5. PubMed ID: 17307653
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
    Johnson CN, Benjamin WH, Gray BM, Crain MC, Edwards KM, Waites KB.
    Int J Antimicrob Agents; 2001 Dec 17; 18(6):531-5. PubMed ID: 11738340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.